Evaluation of Performance of MiYOSMART Photochromic and Clear Spectacle Lenses in Myopic Children
PDIMS
1 other identifier
interventional
202
1 country
1
Brief Summary
This clinical study aims to evaluate the non-inferiority of the photochromic DIMS spectacles lenses performance (PDIMS) compared to clear DIMS spectacles lenses (DIMS) in myopia management.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 23, 2024
CompletedFirst Posted
Study publicly available on registry
December 4, 2024
CompletedStudy Start
First participant enrolled
January 2, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 2, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 2, 2027
December 4, 2024
November 1, 2024
2 years
November 23, 2024
November 29, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Comparing photochromic DIMS spectacles lenses performance (PDIMS) versus clear DIMS spectacles lenses (DIMS)
The primary objective of this study is to evaluate the efficacy of photochromic DIMS spectacles lenses performance (PDIMS) compared to clear DIMS spectacles lenses (DIMS) in terms of childhood myopia control (cycloplegic spherical equivalent refraction (SER), axial elongation and choroidal thickness).
24 months
Secondary Outcomes (1)
Performance of photochromic DIMS spectacles lenses performance (PDIMS) compared to clear DIMS spectacles lenses (DIMS)
24 months
Study Arms (2)
Children on clear DIMS lenses
ACTIVE COMPARATOR202 children will be recruited at 6 institutions following the rules of inclusion and exclusion criteria. Based on a randomization process defined from the study coordinator, children will be allocated to 2 groups: DIMS and PDIMS. The study will be single blinded, meaning that the investigators are not aware of which type of treatment will be associated with which subjects. Subjects cannot be blinded due to the darkening of PDIMS that allows recognition on the type of lens.
Children on photochromic DIMS lenses
ACTIVE COMPARATOR202 children will be recruited at 6 institutions following the rules of inclusion and exclusion criteria. Based on a randomization process defined from the study coordinator, children will be allocated to 2 groups: DIMS and PDIMS. The study will be single blinded, meaning that the investigators are not aware of which type of treatment will be associated with which subjects. Subjects cannot be blinded due to the darkening of PDIMS that allows recognition on the type of lens.
Interventions
Defocus incorporated multiple segments (DIMS) clear vs DIMS photochromic
Eligibility Criteria
You may qualify if:
- Subjects must meet all the criteria listed to participate in the study:
- All ethnicities
- Age between 6 and 15 years
- Refraction -0.50D till - 7.00D and astigmatism ≤ 3.00D
- Anisometropia ≤ 3.00D
- Best corrected monocular distance high contrast VA ≤ 0.10 logMAR
- Normal Binocular vision (fusion and stereopsis)
You may not qualify if:
- Ocular and systemic abnormalities
- Children who do not cooperate
- Binocular vision anomalies (strabismus, suppression)
- Previous use of myopia management treatment (spectacles, atropine, CLs)
- Neurological disorders
- Premature infants
- Children who do not wear their glasses correctly for intermediate and near vision activities
- No informed consent given by parents of child for participation in the clinical study
- Subject is allergic to cycloplegic eye drops
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Singapore National Eye Centre
Singapore, 159029, Singapore
Related Publications (2)
Lam CS, Tang WC, Lee PH, Zhang HY, Qi H, Hasegawa K, To CH. Myopia control effect of defocus incorporated multiple segments (DIMS) spectacle lens in Chinese children: results of a 3-year follow-up study. Br J Ophthalmol. 2022 Aug;106(8):1110-1114. doi: 10.1136/bjophthalmol-2020-317664. Epub 2021 Mar 17.
PMID: 33731364BACKGROUNDLam CSY, Tang WC, Tse DY, Lee RPK, Chun RKM, Hasegawa K, Qi H, Hatanaka T, To CH. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. Br J Ophthalmol. 2020 Mar;104(3):363-368. doi: 10.1136/bjophthalmol-2018-313739. Epub 2019 May 29.
PMID: 31142465BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Consultant
Study Record Dates
First Submitted
November 23, 2024
First Posted
December 4, 2024
Study Start
January 2, 2025
Primary Completion (Estimated)
January 2, 2027
Study Completion (Estimated)
January 2, 2027
Last Updated
December 4, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
- Time Frame
- 2025-2026
- Access Criteria
- Interested investigators
Change in spherical equivalent and axial length over time for further trials in future